NEW YORK (GenomeWeb) – Cancer Genetics reported today that its fourth quarter revenues grew 32 percent year over year.
For the three months ended Dec. 31, 2016, the company reported revenues of $7.2 million up from $5.5 million in Q4 2015.
Get the full story
This story is free
for registered users
Registering provides access to this and other free content.
Register now.Already have an account?
Login Now.